[1]
Silverberg, J.I. et al. 2021. Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis. Acta Dermato-Venereologica. 101, 11 (Nov. 2021), adv00585. DOI:https://doi.org/10.2340/actadv.v101.307.